PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 185 filers reported holding PTC THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is 1.23 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $312,231 | -24.0% | 8,180 | 0.0% | 1.04% | -31.4% |
Q3 2022 | $411,000 | +25.3% | 8,180 | 0.0% | 1.52% | +15.0% |
Q2 2022 | $328,000 | +7.5% | 8,180 | 0.0% | 1.32% | +74.3% |
Q1 2022 | $305,000 | -6.4% | 8,180 | 0.0% | 0.76% | +6.0% |
Q4 2021 | $326,000 | +7.2% | 8,180 | 0.0% | 0.72% | -99.3% |
Q3 2021 | $304,000 | -12.1% | 8,180 | 0.0% | 100.00% | +8056.6% |
Q2 2021 | $346,000 | -10.6% | 8,180 | 0.0% | 1.23% | +11.9% |
Q1 2021 | $387,000 | -22.4% | 8,180 | 0.0% | 1.10% | +134.2% |
Q4 2020 | $499,000 | +30.6% | 8,180 | 0.0% | 0.47% | -93.7% |
Q3 2020 | $382,000 | -8.0% | 8,180 | 0.0% | 7.47% | +406.6% |
Q2 2020 | $415,000 | +13.7% | 8,180 | 0.0% | 1.47% | -18.2% |
Q1 2020 | $365,000 | -7.1% | 8,180 | 0.0% | 1.80% | +7.1% |
Q4 2019 | $393,000 | +41.9% | 8,180 | 0.0% | 1.68% | +30.5% |
Q3 2019 | $277,000 | -24.7% | 8,180 | 0.0% | 1.29% | -29.2% |
Q2 2019 | $368,000 | +19.5% | 8,180 | 0.0% | 1.82% | +778.7% |
Q1 2019 | $308,000 | +9.6% | 8,180 | 0.0% | 0.21% | +1.5% |
Q4 2018 | $281,000 | -26.8% | 8,180 | 0.0% | 0.20% | -20.0% |
Q3 2018 | $384,000 | +39.1% | 8,180 | 0.0% | 0.26% | +119.8% |
Q2 2018 | $276,000 | +24.9% | 8,180 | 0.0% | 0.12% | +20.8% |
Q1 2018 | $221,000 | – | 8,180 | – | 0.10% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Asymmetry Capital Management, L.P. | 110,794 | $3,802,000 | 10.50% |
Boxer Capital, LLC | 2,155,000 | $73,960,000 | 9.14% |
RTW INVESTMENTS, LP | 1,922,346 | $65,975,000 | 6.14% |
GREAT POINT PARTNERS LLC | 1,225,000 | $42,042,000 | 5.31% |
Opaleye Management Inc. | 190,000 | $6,520,000 | 2.43% |
SCOPIA CAPITAL MANAGEMENT LP | 1,626,965 | $55,837,000 | 1.89% |
SPHERA FUNDS MANAGEMENT LTD. | 345,500 | $11,858,000 | 1.34% |
SECTORAL ASSET MANAGEMENT INC | 233,536 | $8,015,000 | 1.09% |
Elk Creek Partners, LLC | 377,674 | $12,962,000 | 1.08% |
Orbimed Advisors | 1,519,700 | $52,156,000 | 0.96% |